IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
RMDL: Classification of Parkinson's disease by nature-inspired Algorithm
Antidiabetic activity (In vitro alpha amylase inhibitory) of ethanol extract of Carissa carandas Linn. roots.
Six sigma: an embellished exploration in the field of pharmaceutical industry
The effect of Sida acuta on bacterial enzymes in azoxymethane-induced experimental colon cancer
Premature ageing in children: a rare genetic disorder called progeria.
Stress, Depression & Gut Microbiota: The Gut-Brain Axis Regulation
Zinc oxide nanoparticles and antibiotics mediated combinatorial approach to enhance antibacterial potential
Quality of life and associated factors among students in Jambi Province, Indonesia
Novel method for simultaneous determination of spiramycin and metronidazole in pharmaceutical dosage form by UV-visible absorption spectrophotometry
The Influence of Physicians Social Capital on Patients Satisfaction
1234
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Nephroprotective potential effect of U-50488H in renal ischemia reperfusion injury in adults Males rats’ model: Role of NRF2 pathway

Author: MARYAM ALAWADI, MUNTHER ABOSAOODA, RASHA HATEM DOSH, MAYSAA ALI ABDUL KALEQ, NAJAH R HADI, WADDAH MAHBOBA
Abstract: Renal ischemia reperfusion injury promotes tissue damage through inducing uncontrolled inflammation, oxidative stress and excessive renal tubular epithelial cell death. Renal ischemia reperfusion injury is one of the main causes of acute kidney injury, it occurs in various clinical situations such as partial nephrectomy, renal transplantation, cardiopulmonary resuscitation, sepsis and shock. Nuclear factor Erythroid 2-related factor 2 pathways are essential in protecting the kidney against renal ischemia reperfusion injury. U-50488H is a highly selective Kappa-opioid receptor agonist. It has anti-inflammatory effect. The present study aims to study the nephro-protective potential effect of U-50488H in renal ischemia reperfusion injury in rats’ model via modulation of Nrf2 pathway. At the end of the experiment, in Control group, as compared with Sham group, the renal tissue levels of Nrf2, HO-1, P-Akt, NF-kB, IL-1ß, F2-isoprostane, NGAL and levels of blood Urea and serum Creatinine were significantly (p?0.05) increased, in addition, Control group causes a significant histopathological tissue damage (p?0.05). Pretreatment with U-50488H exert protective role in the kidney against injury by a significant (p?0.05) more increase in the tissue level of Nrf2, HO-1, P-Akt and decrease in the tissue levels of IL-1ß, NF-kB, F2-isoprostane, NGAL and levels of blood Urea and serum Creatinine. Furthermore, U-50488H a significantly (p?0.05) reverse the severity score of renal tissue damage. From the overall results, we conclude that U-50488H a significantly decrease renal ischemia reperfusion injury in adult male rats model through Nrf2 pathway via it is pleiotropic effects as anti-oxidant, anti-inflammatory and anti-apoptotic.
Keyword: U-50488H in Renal Ischemia/Reperfusion Injury
DOI: https://doi.org/10.31838/ijpr/2020.12.02.0021
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free